Autologous dendritic cell vaccines for non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 22, Issue 14, 2004, Pages 2808-2815

  Hirschowitz, Edward A ^a   Foody, Terry ^a   Kryscio, Richard ^a   Dickson, Larry ^a   Sturgill, Jamie ^a   Yannelli, John ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DENDRITIC CELL VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MELANOMA ANTIGEN; SURVIVIN; WT1 PROTEIN; CANCER VACCINE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSPOT ASSAY; GENE OVEREXPRESSION; GENE THERAPY; HUMAN; IMMUNE RESPONSE; LUNG NON SMALL CELL CANCER; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; AGED; DENDRITIC CELL; IMMUNOLOGY; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

AGED; CANCER VACCINES; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DENDRITIC CELLS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 4344661363     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.074     Document Type: Article

References (29)

1. Spira A, Ettinger DS: Multidisciplinary management of lung cancer. N Engl J Med 350:379-392, 2004
2. Arriagada R, Bergman B, Dunant A, et al: International Adjuvant Lung Cancer Trial Collaborative Group: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004
3. Nemunaitis J, Sterman D, Jablons D, et al: Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer. J Natl Cancer Inst 96:326-331, 2004
4. Gilboa E, Nair SK, Lyerly HK: Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunol Immunotherapy 46:82-87, 1998
5. Timmerman JM, Levy R: Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med, 50:507-529, 1999
6. Conrad C, Nestle FO: Dendritic cell-based cancer therapy. Curr Opin Mol Ther 5:405-412, 2003
7. Keilholz U, Weber J, Finke JH, et al: Immunologic monitoring of cancer vaccine therapy: Results of a workshop sponsored by the Society for Biological Therapy. J Immunother 25:97-138, 2002
8. Cranmer LD, Trevor KT, Hersh EM: Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol Immunother 53:275-306, 2004
9. Fong L, Hou Y, Rivas A, et al: Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A 98:8809-8314, 2001
10. Nair SK, Hull S, Coleman D, et al: Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int J Cancer 82:121-124, 1999
11. Nair SK, Morse M, Boczkowski D, et al: Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann Surg 235:540, 2002
12. Itoh T, Ueda Y, Kawashima I, et al: Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. Cancer Immunol Immunother 51:99-106, 2002
13. Kontani K, Taguchi O, Ozaki Y, et al: Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin. Int J Mol Med 12:493-502, 2003
14. Kato K, Takaue Y, Wakasugi H: T-cell-conditioned medium efficiently induces the maturation and function of human dendritic cells. J Leukoc Biol 70:941-949, 2001
15. Wroblewski JM, Bixby DL, Borowski C, et al: Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens. Lung Cancer 33:181-194, 2001
16. Wong C, Morse M, Nair SK: Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides. J Immunotherapy 21:32-40, 1998
17. Dy GK, Adjei AA: Novel targets for lung cancer therapy: Part I. J Clin Oncol 20:2881-2894, 2002
18. Dy GK, Adjei AA: Novel targets for lung cancer therapy: Part II. J Clin Oncol 20:3016-3028, 2002
19. Gately MK, Wolitzky AG, Quinn PM, et al: Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143:127-142, 1992
20. Trinchieri G: Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027, 1994
21. Macatonia SE, Hosken NA, Litton M, et al: Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154:5071-5079, 1995
22. Kalinski P, Hilkens CM, Wierenga EA, et al: T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal. Immunol Today 20:561-567, 1999
23. Kapsenberg ML, Hilkens CM, Wierenga EA, et al: The paradigm of type 1 and type 2 antigen-presenting cells: Implications for atopic allergy. Clin Exp Allergy 29:S33-S36, 1999
24. Rissoan MC, Soumelis V, Kadowaki IM, et al: Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183-1186, 1999
25. Groux H, Bigler M, de Vries JE, et al: Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184:19-29, 1996
26. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245-252, 1998
27. Banchereau J, Briere F, Caux C, et al: Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811, 2000
28. Itano AA, Jenkins MK: Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol 4:733-739, 2003
29. Cerundolo V, Hermans IF, Salio M: Dendritic cells: A journey from laboratory to clinic. Nat Immunol 5:7-10, 2004